SHANDONG WEIGAO GROUP MEDICAL POLYMER COMPANY LIMITED Hong Kong Exchanges and Clearing Limited and the Stock Exchange of Hong Kong Limited takes no responsibility for the contents of this announcement, makes no representation as to its accuracy or completeness and expressly disclaims any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the contents of this announcement.
Shandong Weigao Group Medical Polymer Company Limited *(a joint stock limited company incorporated in the People's Republic of China with limited liability)
(Stock Code: 1066) AMENDMENT TO DEFINITION
Reference is made to the announcement of Shandong Weigao Group Medical Polymer Company Limited (the "Company") dated 5 January 2015 (the "Announcement") about Connected Transactions in relation to Land Acquisition and Disposal of a Wholly-owned Subsidiary. Unless otherwise defined herein, capitalized terms used in this announcement shall have the same meanings as those defined in the Announcement.
As disclosed under the definition section in the Announcement, "Hai Sheng" referred to JJ#f
#f!li'!f)1lìilffiof!Mii (Weihai Hai Sheng Medical Equipment Company Limited*) which was incorporated on 7 March 2013 in the PRC with limited liability and are held as to 25% and 75% by the Company and Wellford respectively.
By Order of the Board
Chairman
6 January 2015
Weihai, Shandong, the PRC
As at the date of this announcement, the Board comprises:
Mr. Zhang Hua Wei (Executive Director)
Mr. Wang Yi (Executive Director)
Mr. Gong Jian Bo (Executive Director)
Mr. Xia Lie Bo (Executive Director)
Mr. Chen Xue Li (Non-executive Director)
Mrs. Zhou Shu Hua (Non-executive Director)
Mr. Li Jia Miao (Independent non-executive Director)
Mr. Lo Wai Hung (Independent non-executive Director)
Mrs. Wang Jin Xia (Independent non-executive Director)
Mrs. Fu Ming Zhong (Independent non-executive Director)
* For identification purpose only
|
distributed by
|
